![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H14ClNO |
Molar mass | 211.69 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Chlorophenmetrazine (3-CPM, PAL-594) is a recreational designer drug with stimulant effects. It is a substituted phenylmorpholine derivative, closely related to better known drugs such as phenmetrazine and 3-fluorophenmetrazine. It has been shown to act as a monoamine releaser with some preference for dopamine and noradrenaline release over serotonin.[1]
See also
[edit]- 3-Bromomethylphenidate
- 3-Chloromethamphetamine
- 3-Chloromethcathinone
- 4-Methylphenmetrazine
- G-130
- Methylenedioxyphenmetrazine
- Phendimetrazine
- PDM-35
- Radafaxine
References
[edit]- ^ US 20130203752, Blough BE, Rothman R, Landavazo A, Page KM, Decker AM, "Phenylmorpholines and analogues thereof", published 8 August 2013, issued 11 April 2017, assigned to National Institutes of Health, U.S. Department of Health and Human Services